| 000 | 01183 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512033837.0 | ||
| 264 | 0 | _c19860623 | |
| 008 | 198606s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBennett, B M | |
| 245 | 0 | 0 |
_aRequirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cMay 1986 |
||
| 300 |
_a629-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 |
_aHemoglobins _xmetabolism |
| 650 | 0 | 4 |
_aMethemoglobin _xmetabolism |
| 650 | 0 | 4 |
_aMetmyoglobin _xmetabolism |
| 650 | 0 | 4 |
_aMyoglobin _xmetabolism |
| 650 | 0 | 4 |
_aNitrites _xmetabolism |
| 650 | 0 | 4 |
_aNitroglycerin _xanalogs & derivatives |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 700 | 1 | _aKobus, S M | |
| 700 | 1 | _aBrien, J F | |
| 700 | 1 | _aNakatsu, K | |
| 700 | 1 | _aMarks, G S | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 237 _gno. 2 _gp. 629-35 |
|
| 999 |
_c3090566 _d3090566 |
||